Literature DB >> 16583972

Genital prolapse in women of Bhaktapur, Nepal.

Rita Khanal Marahatta1, Aarati Shah.   

Abstract

Genital prolapse is one of the commonest reproductive morbidity in developing country. Common predisposing factors are multiparity, early postpartum sternous activity, advanced age and menopause. This study conducted in Bhaktapur district in five months included 1337 women aged 20 and above. The prevalence of female genital prolapse found to be 7.55%. Maximum numbers of women were having children eight and more (48.51%). Only 1.9% of women with genital prolapse were nulliparous. Home delivery is still common in Bhaktapur, 79% of women with genital prolapse had all children born at home without help. Regarding post partum activity majority of them (64.3%) told that they took rest at least one month after delivery but 26.73% started working in field in 2-3 weeks after delivery. The use of pessary is 25% among female with genital prolapse but only a few were following medical advice to change the ring. Nine women were having impacted ring in situ for years.

Entities:  

Mesh:

Year:  2003        PMID: 16583972

Source DB:  PubMed          Journal:  Nepal Med Coll J


  3 in total

1.  Risk factors for uterine prolapse in Nepal.

Authors:  Barbara Bodner-Adler; Chanda Shrivastava; Klaus Bodner
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2007-03-01

Review 2.  International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs.

Authors:  Heidi W Brown; Aparna Hegde; Markus Huebner; Hedwig Neels; Hayley C Barnes; Gisele Vissoci Marquini; Narmin Mukhtarova; Bernard Mbwele; Visha Tailor; Ervin Kocjancic; Elisa Trowbridge; Lynsey Hayward
Journal:  Int Urogynecol J       Date:  2022-01-03       Impact factor: 2.894

3.  Uterine prolapse and its impact on quality of life in the Jhaukhel-Duwakot Health Demographic Surveillance Site, Bhaktapur, Nepal.

Authors:  Binjwala Shrestha; Sharad Onta; Bishnu Choulagai; Rajan Paudel; Max Petzold; Alexandra Krettek
Journal:  Glob Health Action       Date:  2015-08-10       Impact factor: 2.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.